drugset / Trial / NCT06441266

M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis

NCT06441266 ↗

NaSingle-groupOpen-labelSupportive care

Summary

The purpose of this research study is to test the ability of a mobile device application (MyCap) to collect patient information about their radiation skin rash in patients with head and neck cancer being treated with radiation therapy.

Timeline

Start
2025-05-08
Primary completion
2026-06-08
Completion
2026-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject KeraStat cream Unknown — Topical

Indications